Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
121 studies found for:    Open Studies | "Constipation"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Idiopathic Constipation
Interventions: Drug: Linaclotide 290 micrograms;   Drug: Linaclotide 145 micrograms;   Drug: Linaclotide 72 micrograms
2 Recruiting Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation
Condition: Constipation
Interventions: Drug: Prucalopride;   Drug: Polyethylene glycol (PEG);   Drug: Lactulose
3 Unknown  Treatment of Chronic Constipation in Children With Lactobacillus Reuteri
Condition: Constipation
Interventions: Dietary Supplement: Biogaia;   Other: Placebo
4 Recruiting RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
Conditions: Parkinson's Disease;   Gastroparesis;   Constipation
Interventions: Drug: RQ-00000010;   Drug: Placebo
5 Not yet recruiting Naloxegol in Cancer Opioid-Induced Constipation
Condition: Constipation
Intervention: Drug: naloxegol
6 Not yet recruiting Clinical Trial on Palliative Cancer Patients With Constipation
Condition: Constipation
Interventions: Drug: Chinese herbal medicine;   Drug: Placebo
7 Not yet recruiting The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit
Conditions: Constipation;   Critical Illness
Interventions: Drug: Polyethylene glycol;   Drug: naloxegol
8 Unknown  Pilot Study of the Effect of Lactulose on Post Caesarean Section Constipation
Conditions: Constipation;   Abdominal Pain;   Nausea;   Vomiting
Intervention: Drug: Lactulose
9 Unknown  Anal Dilatation for Infants and Children With Constipation
Condition: Constipation
Intervention: Drug: Lactulose
10 Unknown  Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders
Condition: Constipation
Interventions: Device: Experimental toilet seat;   Device: Standard toilet seat
11 Recruiting Methylnaltrexone for Opioid Induced Constipation
Condition: Constipation
Intervention: Drug: methylnaltrexone
12 Recruiting Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
Conditions: Constipation;   Cancer
Interventions: Drug: PEG then Senna;   Drug: Senna then PEG
13 Unknown  Reflexology for Chronic Constipation
Condition: Chronic Constipation
Intervention: Procedure: Reflexology
14 Unknown  Multistrain Probiotic for Functional Constipation
Condition: Functional Constipation
Interventions: Dietary Supplement: High dose Multistrain probiotic, 100 billion cfu/day;   Dietary Supplement: Low dose Multistrain probiotic, 15 billion cfu/day
15 Unknown  A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Condition: Functional Constipation
Interventions: Drug: Sodium phosphate enema;   Drug: Normal saline enema;   Drug: Mineral oil enema
16 Unknown  Lactobacillus Reuteri in Children With Constipation
Condition: Functional Constipation
Interventions: Dietary Supplement: Lactobacillus reuteri DSM 17938;   Dietary Supplement: Placebo
17 Recruiting The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children
Conditions: Benign Hypermobility Syndrome;   Functional Constipation
18 Recruiting A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
Condition: Chronic Constipation
Interventions: Drug: ASP0456;   Drug: Placebo
19 Unknown  Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children
Conditions: Abdominal Pain;   Constipation - Functional
Interventions: Dietary Supplement: Administration of L.reuteri in children with abdominal pain;   Dietary Supplement: Administration of placebo in children with abdominal pain;   Dietary Supplement: Administration of L.reuteri in children with constipation;   Dietary Supplement: Administration of placebo in children with constipation
20 Unknown  Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
Condition: Opioid-induced Constipation
Interventions: Drug: Methylnaltrexone Bromide;   Drug: Placebo-Normal Saline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years